Cargando…

The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage

BACKGROUND: Chronic inflammation significantly contributes to photoreceptor death in blinding retinal diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Bromodomain and extraterminal domain (BET) proteins are epigenetic readers that act as key proinflammatory fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xingfei, Liu, Wei, Tang, Xiangcheng, Chen, Yulin, Ge, Xiangyu, Ke, Qin, Liang, Xingmiao, Gan, Yuwen, Zheng, Yingfeng, Zou, Ming, Deng, Mi, Liu, Yizhi, Li, David Wan-Cheng, Gong, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201800/
https://www.ncbi.nlm.nih.gov/pubmed/37217935
http://dx.doi.org/10.1186/s12974-023-02804-y
_version_ 1785045328293003264
author Zhu, Xingfei
Liu, Wei
Tang, Xiangcheng
Chen, Yulin
Ge, Xiangyu
Ke, Qin
Liang, Xingmiao
Gan, Yuwen
Zheng, Yingfeng
Zou, Ming
Deng, Mi
Liu, Yizhi
Li, David Wan-Cheng
Gong, Lili
author_facet Zhu, Xingfei
Liu, Wei
Tang, Xiangcheng
Chen, Yulin
Ge, Xiangyu
Ke, Qin
Liang, Xingmiao
Gan, Yuwen
Zheng, Yingfeng
Zou, Ming
Deng, Mi
Liu, Yizhi
Li, David Wan-Cheng
Gong, Lili
author_sort Zhu, Xingfei
collection PubMed
description BACKGROUND: Chronic inflammation significantly contributes to photoreceptor death in blinding retinal diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Bromodomain and extraterminal domain (BET) proteins are epigenetic readers that act as key proinflammatory factors. We recently found the first-generation BET inhibitor JQ1 alleviated sodium iodate-induced retinal degeneration by suppressing cGAS-STING innate immunity. Here, we investigated the effects and mechanism of dBET6, a proteolysis‑targeting chimera (PROTAC) small molecule that selectively degrades BET by the ubiquitin‒proteasome system, in light-induced retinal degeneration. METHODS: Mice were exposed to bright light to induce retinal degeneration, and the activation of cGAS-STING was determined by RNA-sequencing and molecular biology. Retinal function, morphology, photoreceptor viability and retinal inflammation were examined in the presence and absence of dBET6 treatment. RESULTS: Intraperitoneal injection of dBET6 led to the rapid degradation of BET protein in the retina without detectable toxicity. dBET6 improved retinal responsiveness and visual acuity after light damage (LD). dBET6 also repressed LD-induced retinal macrophages/microglia activation, Müller cell gliosis, photoreceptor death and retinal degeneration. Analysis of single-cell RNA-sequencing results revealed cGAS-STING components were expressed in retinal microglia. LD led to dramatic activation of the cGAS-STING pathway, whereas dBET6 suppressed LD-induced STING expression in reactive macrophages/microglia and the related inflammatory response. CONCLUSIONS: This study indicates targeted degradation of BET by dBET6 exerts neuroprotective effects by inhibiting cGAS-STING in reactive retinal macrophages/microglia, and is expected to become a new strategy for treatment of retinal degeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02804-y.
format Online
Article
Text
id pubmed-10201800
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102018002023-05-23 The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage Zhu, Xingfei Liu, Wei Tang, Xiangcheng Chen, Yulin Ge, Xiangyu Ke, Qin Liang, Xingmiao Gan, Yuwen Zheng, Yingfeng Zou, Ming Deng, Mi Liu, Yizhi Li, David Wan-Cheng Gong, Lili J Neuroinflammation Research BACKGROUND: Chronic inflammation significantly contributes to photoreceptor death in blinding retinal diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Bromodomain and extraterminal domain (BET) proteins are epigenetic readers that act as key proinflammatory factors. We recently found the first-generation BET inhibitor JQ1 alleviated sodium iodate-induced retinal degeneration by suppressing cGAS-STING innate immunity. Here, we investigated the effects and mechanism of dBET6, a proteolysis‑targeting chimera (PROTAC) small molecule that selectively degrades BET by the ubiquitin‒proteasome system, in light-induced retinal degeneration. METHODS: Mice were exposed to bright light to induce retinal degeneration, and the activation of cGAS-STING was determined by RNA-sequencing and molecular biology. Retinal function, morphology, photoreceptor viability and retinal inflammation were examined in the presence and absence of dBET6 treatment. RESULTS: Intraperitoneal injection of dBET6 led to the rapid degradation of BET protein in the retina without detectable toxicity. dBET6 improved retinal responsiveness and visual acuity after light damage (LD). dBET6 also repressed LD-induced retinal macrophages/microglia activation, Müller cell gliosis, photoreceptor death and retinal degeneration. Analysis of single-cell RNA-sequencing results revealed cGAS-STING components were expressed in retinal microglia. LD led to dramatic activation of the cGAS-STING pathway, whereas dBET6 suppressed LD-induced STING expression in reactive macrophages/microglia and the related inflammatory response. CONCLUSIONS: This study indicates targeted degradation of BET by dBET6 exerts neuroprotective effects by inhibiting cGAS-STING in reactive retinal macrophages/microglia, and is expected to become a new strategy for treatment of retinal degeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02804-y. BioMed Central 2023-05-22 /pmc/articles/PMC10201800/ /pubmed/37217935 http://dx.doi.org/10.1186/s12974-023-02804-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhu, Xingfei
Liu, Wei
Tang, Xiangcheng
Chen, Yulin
Ge, Xiangyu
Ke, Qin
Liang, Xingmiao
Gan, Yuwen
Zheng, Yingfeng
Zou, Ming
Deng, Mi
Liu, Yizhi
Li, David Wan-Cheng
Gong, Lili
The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
title The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
title_full The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
title_fullStr The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
title_full_unstemmed The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
title_short The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
title_sort bet protac inhibitor dbet6 protects against retinal degeneration and inhibits the cgas-sting in response to light damage
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201800/
https://www.ncbi.nlm.nih.gov/pubmed/37217935
http://dx.doi.org/10.1186/s12974-023-02804-y
work_keys_str_mv AT zhuxingfei thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT liuwei thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT tangxiangcheng thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT chenyulin thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT gexiangyu thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT keqin thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT liangxingmiao thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT ganyuwen thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT zhengyingfeng thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT zouming thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT dengmi thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT liuyizhi thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT lidavidwancheng thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT gonglili thebetprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT zhuxingfei betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT liuwei betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT tangxiangcheng betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT chenyulin betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT gexiangyu betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT keqin betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT liangxingmiao betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT ganyuwen betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT zhengyingfeng betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT zouming betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT dengmi betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT liuyizhi betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT lidavidwancheng betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage
AT gonglili betprotacinhibitordbet6protectsagainstretinaldegenerationandinhibitsthecgasstinginresponsetolightdamage